Related Experiment Video
Updated: May 4, 2026

10:53
Functional Imaging of Brown Fat in Mice with 18F-FDG micro-PET/CT
Published on: November 23, 2012
18.8K
Fully automated radiosynthesis of [18F]FCPPC for imaging microglia with PET
Pritam Roy1,2,3, Yan Guo1,2,3, Otto Muzik2,4
1Cyclotron and Radiochemistry Core, Karmanos Cancer Institute Detroit, MI, USA.
American Journal of Nuclear Medicine and Molecular Imaging
|January 22, 2025
Summary
We developed an automated method to synthesize [18F]FCPPC, a novel radiotracer for Positron Emission Tomography (PET) imaging. This advancement enables efficient and high-purity production of [18F]FCPPC for human microglia imaging and neuroinflammation studies.
Area of Science:
- Neuroscience
- Radiochemistry
- Medical Imaging
Background:
- Colony-stimulating factor 1 receptor (CSF1R) is a key marker for microglia in the human brain, making it a potential target for neuroinflammation imaging.
- [11C]CPPC is a radiotracer for CSF1R, but its fluorine-18 labeled analog, [18F]FCPPC, had low yields with manual synthesis.
- Efficient and reliable production of [18F]FCPPC is crucial for its clinical application in microglia PET imaging.
Purpose of the Study:
- To develop and validate a fully automated radiosynthesis of the fluorine-18 labeled radiotracer [18F]FCPPC.
- To optimize the production of [18F]FCPPC for high radiochemical yield and purity.
- To establish [18F]FCPPC as a viable tool for human microglia PET imaging.
Main Methods:
- Automated radiosynthesis of [18F]FCPPC was performed using a Synthra RNplus research module.
- The synthesis process was optimized for speed and efficiency, aiming for a total synthesis time under 1 hour.
- Quality control tests were conducted to ensure the radiochemical purity and suitability of the final product for imaging.
Main Results:
- The automated radiosynthesis yielded [18F]FCPPC in a decay-corrected radiochemical yield of 26.8 ± 0.1% (n=3) within 50 minutes.
- Radiochemical purities consistently exceeded 99%.
- The synthesized [18F]FCPPC met all predefined quality control release criteria.
Conclusions:
- The first fully automated radiosynthesis of [18F]FCPPC has been successfully established.
- This automated method provides a reliable and efficient way to produce [18F]FCPPC for clinical use.
- [18F]FCPPC is a promising radiopharmaceutical for non-invasive imaging of microglia density and neuroinflammation in humans.
Keywords:
Colony-stimulating factor 1 receptorPET imaging[18F]FCPPCautomationradiopharmaceuticalradiosynthesisMore Related Videos
Related Concept Videos
Positron Emission Tomography
6.2K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.2K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
853
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
853
![Automated Radiochemical Synthesis of [18F]3F4AP: A Novel PET Tracer for Imaging Demyelinating Diseases](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F55537.jpg&w=3840&q=50)
